Homatropine and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Homatropine and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: homatropine ophthalmic
Brand name: Isopto Homatropine, Homatropaire
Synonyms: Homatropine ophthalmic
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Homatropine-Lithium ER
- Homatropine-Lithium Oral Solution
- Homatropine-Lithium Salts
- Homatropine-Lithium Syrup and Oral Solution
- Homatropine-Lithobid
- Homatropine-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Homatropine and hydrocodone
- Lithium Controlled-Release and Extended-Release Tablets-Homatropine Hydrobromide
- Lithium Controlled-Release and Extended-Release Tablets-Homatropine ophthalmic
- Lithium Controlled-Release and Extended-Release Tablets-Homatropine Ophthalmic Solution
- Lithium Controlled-Release and Extended-Release Tablets-HOME PAPKIT
- Lithium Controlled-Release and Extended-Release Tablets-Homocysteine Formula